Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide by Huan He et al.
RESEARCH ARTICLE Open Access
Alkaloids from piper longum protect
dopaminergic neurons against
inflammation-mediated damage induced
by intranigral injection of lipopolysaccharide
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Abstract
Background: Alkaloids from Piper longum (PLA), extracted from P. longum, have potent anti-inflammatory effects.
The aim of this study was to investigate whether PLA could protect dopaminergic neurons against inflammation-
mediated damage by inhibiting microglial activation using a lipopolysaccharide (LPS)-induced dopaminergic
neuronal damage rat model.
Methods: The animal behaviors of rotational behavior, rotarod test and open-field test were investigated. The
survival ratio of dopaminergic neurons and microglial activation were examined. The dopamine (DA) and its
metabolite were detected by high performance liquid chromatography (HPLC). The effects of PLA on the
expression of interleukin (IL)-6, interleukin (IL)-1β and tumor necrosis factor (TNF)-α were detected by enzyme-linked
immunosorbent assay (ELISA). Reactive oxygen species (ROS) and nitric oxide (NO) were also estimated.
Results: We showed that the survival ratio of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the substantia
nigra pars compacta (SNpc) and DA content in the striatum were reduced after a single intranigral dose of LPS
(10 μg) treatment. The survival rate of TH-ir neurons in the SNpc and DA levels in the striatum were significantly
improved after treatment with PLA for 6 weeks. The over-activated microglial cells were suppressed by PLA
treatment. We also observed that the levels of inflammatory cytokines, including TNF-α, IL-6 and IL-1β were
decreased and the excessive production of ROS and NO were abolished after PLA treatment. Therefore, the
behavioral dysfunctions induced by LPS were improved after PLA treatment.
Conclusion: This study suggests that PLA plays a significant role in protecting dopaminergic neurons against
inflammatory reaction induced damage.
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Background
Parkinson’s disease (PD) is one of the most common
neurodegenerative disease, characterized by slow and
progressive death of dopaminergic neurons in the
substantia nigra pars compacta (SNpc) [1]. Although
the mechanism of neuronal degeneration remains not
throughly elucidated, increasing evidences suggest that
neuroinflammatory processes may be involved in the
progressive death of dopaminergic neurons [2–4].
Studies have shown that the activation of microglia
plays a key role in neuroinflammation and a large
quantity of reactive microglia was found in the SNpc
of PD patient [5, 6]. Under normal circumstances,
microglia typically exists in a resting state, which involved
in immune surveillance and host defense against immu-
nological stimuli. However, it comes to be activated
when various pathogenic stimuli appear such as brain
injury [7, 8]. Over-activated microglia produces various
neurotoxic factors, such as nitric oxide (NO), tumor
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necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β),
prostaglandin E2 (PGE2), and reactive oxygen species
(ROS), which lead to neuronal damage and results in a
self-amplifying cycle of neuronal death [8, 9].
In the past, levodopa is the most widely used drugs for
PD treatment, which mainly focused on dopamine (DA)
compensation. But years of levodopa treatment causes
motor complications, dyskinesia and its efficacy is coun-
teracted [10]. Therefore, new drugs with novel mechan-
ism for the treatment of PD are urgently needed. Several
reports have shown that a number of traditional Chinese
Medicine have neurotrophic and neuroprotective pro-
perties in PD animal models [11–13].
Piper longum L. (Piperaceae) has been used as tra-
ditional medicine in Asia and the Pacific Islands. Piperine
is a main compound in P. longum. Alkaloids from Piper
longum (PLA) are extracted from P. longum seed. It
mainly contains 53.08 % piperine and 1.73 % piperlongu-
minine. Our previous work revealed that PLA possess
neuroprotection function on dopaminergic neurons
against 6-OHDA-induced damage and in the MPTP
animal model of PD [14, 15]. Recently, another report
showed that piperine and piperlonguminine protect
rotenone-induced neuronal injury [16]. Besides, our
previous work also showed that PLA significantly sup-
pressed BV2 cells activation, attenuated expression of
cyclooxygenase (COX)-2 and inhibited the excessive
production of proinflammatory mediator IL-1β and
PGE2 in LPS-induced BV2 cells [17].
Based on the previous studies, we hypothesized that
PLA showed neuroprotective effects by reducing inflam-
mation. In the present study, we used the classic lipo-
polysaccharide (LPS)-induced rat model of PD to
examine whether PLA protects dopaminergic neurons
against inflammation-mediated damage by inhibiting
microglial activation.
Methods
PLA extract and reagents
Piper longum was purchased from Anguo, Hebei province,
China, in 2014 and identified by Rong Luo, associate
professor, School of Traditional Chinese Medicine, Capital
Medical University. The voucher specimens of this mater-
ial have been deposited in School of Traditional Chinese
Medicine, Capital Medical University.
The PLA extract was made as our previous work
described [15]. The content of total alkaloids was 74.6 %
determined by UV, meanwhile the contents of piperine
and piperlonguminine were 53.08 and 1.73 % respectively
determined by HPLC. PLA was analyzed in a previous
study carried out by our laboratory. Refer to this
work for information about detailed compositions and
chromatogram of PLA [15].
Lipopolysaccharide (LPS, from Escherichia coli. serotype
O26:B6), dopamine (DA), 3,4-dihydroxyphenylacetic acid
(DOPAC), mouse anti-tyrosine hydroxylase antibody,
TritonX-100 and apomorphine were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Rabbit anti-Iba-1
antibody was purchased from BOSTER (Wuhan, China).
Interleukin-1β (IL-6), interleukin-1β (IL-1β), tumor necro-
sis factor-alpha (TNF-α) and reactive oxygen species
(ROS) enzyme-linked immunosorbent assay (ELISA)
kits were purchased from MultiScience Biotech Co., Ltd
(Hangzhou, China). Nitric oxide (NO) kit was purchased
from NanjingJiancheng Bioengineering Institute (Jiangsu,
China).
Animals and surgery
Eighty adult male Sprague-Dawley rats (weight 260–300 g)
were purchased from the Beijing Vital River Lab Animal
Technology Co. Ltd. (Beijing, China) and maintained
under standard conditions with a standard 12-h on/off
light cycle, with food and water supplied ad libitum.
After allowed to acclimate to their new surroundings
for 1 week before experimental surgery, the rats were
injected 2.0 μL LPS dissolved (5 mg/mL) in phosphate-
buffed saline (PBS) into the right SNpc following a previ-
ous described protocol [18]. The injection position was
anteroposterior −5.3 mm, lateral 2.0 mm and dorsoventral
7.8 mm from bregma. Sham-operated animals were
injected 2 μL PBS into the right SNpc. Our reasearch
had acquired the ethics approval by Animal Experiments
and Experimental Animal Welfare Committee of Capital
Medical University and all experimental procedures
were approved by the Committee. The ethics approval
number is AEEI-2014-081.
Experiment design
The rats were randomly divided into five groups: the
sham-operated group (n = 16), the LPS-injected group
followed by vehicle treatment (model group, n = 16), the
LPS-injected group followed by treatment with 25, 50
and 75 mg/kg PLA, respectively (n = 16 each group).
Rats in three PLA treatment groups were intragastrically
administered with PLA (dissolved in 0.5 % sodium
carboxymethylcellulose) once a day after the surgery
for 6 weeks. The sham-operated and model groups
received 0.5 % sodium carboxymethylcellulose.
Rotational behavior assay
On the second day after treatment with PLA for 3 and
6 weeks, the rats were injected hypodermically with
0.5 mg/kg apomorphine dissolved in physiological saline
to examine the rotational behavior. The number of turns
performed over 30-min testing period was counted.
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Rotarod test
All rats underwent a 3-day training program on a
rotarod before the LPS injection, by which time a steady
baseline level of rotarod performance was attained.
Briefly, the rats were placed on the rod and sequentially
tested at the speed accelerated from 0 to 40 rpm within
2 min. The time latency to fall from the rotarod at
each speed level was recorded. At 3th and 6th week after
treatment with PLA the rats were tested respectively.
Open-field test
Rats in each group were tested by the Tru Scan activity
monitoring system (Coulbourn Instruments), which
contains acoustic insulation and lucifugal field (60 cm×
60 cm× 65 cm). Infrared device was installed at the top of
the box, which was used to accurately track the movement
and the behavior. After the end of each test, 75 % ethanol
was used to thoroughly clean the open-field apparatus.
The rat movement was recorded for the following para-
meters: total movement distance (cm), total movement
time (s), total rest time (s) and horizontal velocity (cm/s).
Each test time was 30 min.
Preparation of tissue samples
Four rats from each group were randomly selected for
morphological studies on the second day after the final
behavioral tests. Decapitating all other rats, then the
bilateral substantia nigra (SN) and striatum were rapidly
dissected and stored at −80 °C. The SN was used for
the quantification of proinflammatory cytokines, and
the striatum for determination of the content of DA.
For the morphological studies, rats were deeply anes-
thetized with chloral hydrate, then transcardially per-
fused with 200 mL saline followed by 200 mL of 4 %
paraformaldehyde in 0.1 M phosphate buffer. Brains
were removed and post-fixed in the same fixative and
then immersed in a 20 % sucrose solution and a 30 %
sucrose solution. Coronal section were cut on a freezing
microtome (Leica, Germany) at a thickness of 40 μm and
used for immunohistochemistry as described below.
High performance liquid chromatography (HPLC)
The determination of DA and its metabolite 3,4-dihy-
droxyphenylacetic acid (DOPAC) was carried out using
HPLC with a Coul Array electrochemical detector
(Model 5600A, ESA, USA) equipped with Waters sym-
metry shield RP 18 column (150 × 3.9 mm, 5 μm).
The mobile phase consisted of 50 mM sodium citrate,
8 % methanol, 0.1 mM EDTA · 2Na, 0.2 mM 1-octa
nesulfonic acid sodium salt and was finally adjusted
to pH 4.1. The flow rate was 0.8 mL/min. Striatum
tissues from 6 animals of each group were used and
performed as described in previous work [19].
Immunohistochemical staining of TH and Iba-1
Eight sections were selected for immunohistochemical
staining of the tyrosine hydroxylase (TH). The mouse
anti-TH antibody was diluted at 1:2000. Adjacent
sections were used for detection of microglial marker
Iba-1. The rabbit anti-Iba-1 antibody was diluted at
1:200. Sections were perforated with 0.3 % Triton-X
100 and blocked with normal horse serum (1:100 dilu-
tion), then were incubated with primary antibodies for
24 h at 4 °C. After that, sections were incubated with
biotinylated anti-mouse antibody and biotinylated anti-
rabbit antibody (Vector laboratories, Burlingame, CA,
USA) respectively for 30 min at 37 °C, followed by avidin-
biotin-peroxidase (Vector laboratories, Burlingame, CA,
USA) incubation for 30 min at 37 °C. Finally, the immune
complex was detected by 3, 3’ - diaminobenzidine (DAB).
To measure the numbers of TH-ir cells in the SN,
stereological cell counting was performed. The optical
fractionator method on a Stereo Investigator system
(Micro Bright Field, USA) was used to count the total
numbers of TH-ir neurons in the SN and a Leica micro-
scope was used. The survival rate of TH-ir neurons in
the SN was determined by counting the number of
TH-ir neurons on LPS-injected side relative to the
number of TH-ir neurons on the non-injected side.
Quantitative analysis of Iba-1-stained immunohisto-
chemical images were carried out with an Image-Pro
Plus 6.0 system and positive results were expressed as
average optical density value. All sections were coded
and examined blindly.
IL-6, IL-1β and TNF-α immunoassay
The right SN was used to detect the proinflammatory
cytokines. Tissues were made into 10 % homogenate and
then the homogenate was centrifuged at 3000 g for
15 min at 4 °C. The supernatant was collected at 4 °C.
IL-6, IL-1β and TNF-α were detected using the commer-
cial enzyme-linked immunosorbent assay (ELISA) kits
(MultiScience Biotech, Hangzhou, China). All experi-
mental procedures were performed according to the
manufacturer’s instructions. Besides, we used the BCA
protein kit to measure protein contents in samples
according to the manual. The SN tissues from 6 animals
of each group were used.
Measurement of ROS and NO
The SN was also used to measure ROS and NO and
tissues were made into 10 % homogenate as above. ROS
was measured using enzyme-linked immunosorbent
assay (ELISA) to measure absorbance value at 450 nm
with ELISA kit. The content of NO was measured using
NO assay kit according to the manufacturer’s guidelines
by measuring the absorbance value at wavelength of
550 nm. BCA protein kit was used to measure the
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protein contents in samples according to the manual.
The SN tissues from 6 animals of each group were used.
Statistical analysis
Data were processed by commercially available software
GraphPad Prism 5.0. Results are typically presented as
means ± S.E.M. Statistical significance was assessed using
a one-way analysis of variance (ANOVA), followed by
Dunnett post hoc test (compares all the other columns
with the designated control column). Significance was
set at P < 0.05.
Results
PLA administration improves apomorphine-induced
rotational behavior
The apomorphine-induced rotational cycles of all groups
are shown in Fig. 1. The rotational cycles of model
group animals increased than that of sham group (P <
0.001) examined both at 3th and 6th week after LPS
injection. However, treatment with 25, 50 and 75 mg/kg
PLA for 6 weeks significantly reduced the numbers of
apomorphine-induced rotational turns compared with
the model group (P < 0.001) (Fig. 1b).
PLA administration improves rotarod behavior
As apomorphine-induced rotation test, the rotarod test
is also a classic method to evaluate behavioral dysfunc-
tion of PD model rats. Animals in each group performed
equally before LPS injection (Fig. 2a). A significant
decrease of time which rats keep balance on rod was
observed after LPS injection for 3 and 6 weeks (P <
0.001) (Fig. 2). However, treatment with PLA (25, 50 and
75 mg/kg) for 6 weeks may significantly improve the
rotarod behavior (Fig. 2c).
PLA administration improves locomotor activity
Open-field test is a classic behavioral test to comprehen-
sively evaluate spontaneous behaviors of rats. The results
showed that the most activities in the model group were
significantly reduced than other groups. As shown in
Fig. 3a, b, d, the activities of model group such as total
movement distance, total movement time and horizontal
velocity were all decreased. In contrast, the rest time for
Fig. 1 Effects of PLA treatment on apomorphine-induced rotational behavior. Rats were randomly grouped and then treated with PLA (25, 50 and
75 mg/kg) or vehicle for 6 weeks after LPS injection. On day 21 a and 42 b, rats were hypodermically injected with apomorphine (0.5 mg/kg) to induce
rotational behavior. The number of turns were recorded for 30 min. n = 10–14. ***P < 0.001 vs. sham group, #P < 0.05, ###P < 0.001 vs. LPS group
Fig. 2 Effects of PLA treatment on rotarod behavior. Rats were randomly grouped and then treated with PLA (25, 50 and 75 mg/kg) or vehicle
for 6 weeks after LPS injection. a A baseline trial was conducted before surgery. b, c The time each group animals remained on the rotarod after
PLA administration for 3 and 6 weeks, respectively. n = 10–13. ***P < 0.001 vs. sham group, ##P < 0.01, ###P < 0.001 vs. LPS group
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Fig. 3 Effects of PLA treatment on locomotor activity. Rats were randomly grouped and then treated with PLA (25, 50 and 75 mg/kg) or vehicle
for 6 weeks after LPS injection. On day 42, rats were placed into open-field apparatus, and spontaneous behaviors of 30 min was measured and
analyzed by a Tru Scan 2.01 software. a total movement distance; b total movement time; c total rest time; d horizontal velocity. n = 10–11.
***P < 0.001 vs. sham group, ##P < 0.01, ###P < 0.001 vs. LPS group
Fig. 4 Effects of PLA treatment on the movement track of rats. a sham-operated group; b LPS-injected group followed by vehicle treatment;
c the LPS-injected group followed by treatment with 25 mg/kg PLA; d the LPS-injected group followed by treatment with 50 mg/kg PLA;
e the LPS-injected group followed by treatment with 75 mg/kg PLA
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Fig. 5 Effects of PLA treatment on the contents of DA and DOPAC in the striatum. Rats were randomly grouped and then treated with
PLA (25, 50 and 75 mg/kg) or vehicle for 6 weeks after LPS injection. On day 42, rats were decapitated and the contents of DA and
DOPAC in the striatum were detected by HPLC. The survival ratios (right relative to left side) of DA a and DOPAC b were calculated.
n = 6. ***P < 0.001 vs. sham group, #P < 0.05, ##P < 0.01 vs. LPS group
Fig. 6 Morphological evidence of the protective effect of PLA against LPS-induced damage to dopaminergic neurons in the SN. Rats were
randomly grouped and then treated with PLA (25, 50 and 75 mg/kg) or vehicle for 6 weeks after LPS injection. On day 42, rats were
deeply anesthetized and transcardially perfused with 4 % paraformaldehyde and processed as above. Frozen sections at a thickness of
40 μm were cut and TH was detected by immunohistochemical staining to show dopaminergic neurons in the SNpc. (A1–A4) sham-operated
group, TH staining was similar on the non-injected (A2) and injected (A3) side; (B1–B4) model group, LPS-injected followed by vehicle treatment,
an obvious loss of TH-ir cells was seen on the injected side (B3); (C1–C4, D1–D4, and E1–E4) the LPS-injected group followed by treatment with 25,
50 and 75 mg/kg PLA respectively, much more TH-ir neurons survived on the LPS-injected side compared to model group
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the rats in the model group was significantly higher than
the others (Fig. 3c). Treatment with PLA (25, 50 and
75 mg/kg) for 6 weeks significantly increased the total
movement distance, total movement time and horizontal
velocity and decreased the rest time. Figure 4 shows the
effect of PLA on the movement track of 30 min of rats
in each group.
PLA administration attenuates depletion of DA and
DOPAC in the striatum induced by LPS intranigral
injection
The DA content in striatum was decreased after injec-
tion of LPS in the SN. In the model group, the survival
levels of DA and DOPAC on the LPS-injected side were
much lower than that of sham group (P < 0.001). After
treatment with PLA 50 or 75 mg/kg for 6 weeks, the DA
and DOPAC depletion in the striatum induced by LPS
intranigral injection was significantly attenuated (Fig. 5).
PLA treatment protects dopaminergic neurons from the
injury induced by LPS intranigral injection
Representative microphotographs of TH immunohisto-
chemical staining in the SNpc are shown in Fig. 6. The
numbers of TH-ir neurons on the injection side and non-
injection side were similar in sham-operated animals.
Model group rats showed a marked loss of TH-ir neurons
and their dendrites on the injection side. However,
PLA (25, 50 and 75 mg/kg) treatment significantly recov-
ered this loss of nigral TH immunoreactivity. The survival
ratio of dopaminergic neuron on the LPS-injected side
relative to the non-injected side was shown in Fig. 7.
Compared with the sham group, the survival of TH-ir
neurons in the SNpc of model group was significantly de-
creased (P < 0.001). In contrast, the rats treated with 50
and 75 mg/kg PLA after LPS injection showed a great in-
crease in the survival rate of TH-ir neurons in the SNpc
when compared to model group rats (P < 0.01). A low
dose (25 mg/kg) of PLA showed an obvious trend toward
increasing the survival of TH-ir neuros in the SNpc, al-
though not statistically significant.
PLA treatment inhibits microglial activation in the SNpc
induced by LPS intranigral injection
Immunocytochemical staining of ionized calcium binding
adaptor molecule-1 (Iba-1) antibody was used to reveal
microglial activation. As shown in Fig. 8, microglia
underwent a morphological change from resting state
Fig. 7 Effects of PLA treatment on the survival ratio of dopaminergic
neurons in the SNpc. The numbers of TH-ir neurons in the SNpc were
counted as described in methods. Survival ratio of the TH-ir neurons in
the SNpc (the injected side relative to the non-injected side) was
calculated. n = 4. ***P < 0.001 vs. sham group, ##P < 0.01 vs. LPS group
Fig. 8 PLA treatment inhibits microglial activation. The morphological changes of microglia in the SNpc were revealed by Iba-1 immunostaining.
Representative micrographs were shown. Scale bar represents 100 μm
He et al. BMC Complementary and Alternative Medicine  (2016) 16:412 Page 7 of 11
to activated cells with larger cell body and branching
coarsening in the SNpc after LPS injection. However,
the activation of microglia was significantly suppressed
after PLA treatment. The average optical density value
was shown in Fig. 9. Compared with the sham group, the
Iba-1 content increased significantly in the LPS injection
group (P < 0.001), but which was significantly decreased
after treatment with PLA for 6 weeks (P < 0.001).
PLA treatment inhibits the release of TNF-α, IL-6 and
IL-1β in the SN induced by LPS intranigral injection
Intranigral injection of LPS induced excessive release
of proinflammatory cytokines. The concentrations of
proinflammatory cytokines TNF-α, IL-6 and IL-1β in the
SN of model group rats were significantly increased when
compared with the sham-operated group rats (P < 0.01).
Treatment with PLA 50 and 75 mg/kg for 6 weeks
significantly decreased the concentrations of TNF-α, IL-6
and IL-1β when compared with model group (P < 0.05).
Rats treated with 25 mg/kg PLA, only the IL-6 concen-
tration was decreased significantly compared with model
group (P < 0.05) (Fig. 10).
PLA treatment inhibits the release of ROS and NO in the
SN induced by LPS intranigral injection
To demonstrate if PLA protecting the dopaminergic neu-
rons is related to inhibiting the release of ROS and NO,
the concentrations of ROS and NO in the SN were ob-
served. The data showed that the concentrations of ROS
and NO in model group rats were markedly increased
compared with sham-operated group rats (P < 0.01). The
concentrations of ROS and NO of rats treated with 50
and 75 mg/kg PLA for 6 weeks were fewer than that of
rats in model group (P < 0.05). Rats treated with 25 mg/kg
PLA, only the NO concentration showed a significant
decrease compared with model group (P < 0.05) (Fig. 11).
Discussion
A number of researches have suggested that inflamma-
tory process plays a significant role in the progression
of PD, especially microglial activation [8, 9, 20]. LPS,
a component of the cell wall of Gram-negative bacterial,
is extensively used to induce inflammation by activate
glial cell [18, 19]. The PD models induced by LPS
both in vitro and in vivo are widely used, which can
not only reflect the role of neuroinflammation in PD but
also have been used in drug discovery [21–23]. For
example, pioglitazone and naloxone have been studied
for their potential neuroprotective effects on LPS-induced
PD models [24, 25]. It was reported that, the inflammatory
reaction induced by injecting LPS into SN had a selective
irreversible and long lasting damage on the dopaminergic
neurons, which ultimately resulted in neurodegeneration
[20, 22, 26]. Many studies also showed that a single
Fig. 10 Effects of PLA treatment on the concentrations of proinflammatory cytokines in the SN. Rats were randomly grouped and then
treated with PLA (25, 50 and 75 mg/kg) or vehicle for 6 weeks after LPS injection. On day 42, rats were decapitated and the SN was
used to detect the concentrations of TNF-α a IL-6 b and IL-1β c by commercial ELISA kit. n = 6. **P < 0.01, ***P < 0.001 vs. sham group,
#P < 0.05, ##P < 0.01 vs. LPS group
Fig. 9 Effects of PLA treatment on the average optical density of
Iba-1 in the SNpc. n = 4. ***P < 0.001 vs. sham group, ###P < 0.001
vs. LPS group
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intranigral injection of LPS led to depletion of DA and
loss of dopaminergic neurons in animals [21, 27, 28].
In the present study, the effect of PLA on LPS
induced rat model was examined and three different
behavioral tests were conducted. The apomorphine-in-
duced rotational test was used to estimate the injury de-
gree of dopaminergic system [29]. Apomorphine-induced
rotation cycles signifcantly increased in the model group
rats induced by intranigral injection of LPS, in con-
trast, PLA treatment showed an improvement effect
on this behavioral dysfunction (Fig. 1). The other two
behavioral dysfunctions were also significantly im-
proved by PLA treatment measured by rotarod test
and open-field test. Further studies suggested that
PLA treatment was able to block the loss of TH-ir
neurons in the SNpc in LPS intranigral injection rats.
Studies have shown that microglial cells are readily
activated and a variety of neurotoxic factors exist in
the SN of LPS-induced PD model rats, which cause the
damage of dopaminergic neurons [30–33]. The neurotoxic
factors include IL-6, IL-1β, TNF-α, O2
−, NO and so on
[33, 34]. Our previous work suggested that PLA could
significantly inhibit LPS-induced BV2cell activation
and proinflammatory mediator production, such as
IL-1β [17]. In the present study, our results showed
that an intranigral injection of LPS led the microglial
over-activation and the production of a large amount
of neurotoxic proinflammatory factors (TNF-α, IL-6
and IL-1β), which triggered the cascade of events and
caused the death of neighboring dopaminergic neurons,
in contrast, PLA treatment was able to suppress the
activation of microglia and block the release of these
proinflammatory cytokines, attenuate neuroinflamma-
tion, and protect dopaminergic neurons damage. Given
our previous work that PLA could cross the blood-brain
barrier [35], these data indicates that PLA has potent
anti-inflammatory activity in the central nervous system.
Nuclear factor κB (NF-κB) signaling pathway is the most
significant pathway which mediates the LPS-induced
microglial inflammatory response and regulates the pro-
duction of various inflammatory mediators [29, 30]. In
our previous work, the role of PLA in modulating NF-κB
pathway in BV2 cells was studied [17]. PLA could inhibit
the nuclear translocation of p65 subunit of NF-κB. The
p65 protein level in the nucleus was increased after LPS
stimulation, however PLA treatment significantly counter-
acted it. What’s more, PLA could also inhibit NF-κB
activity through the inhibitory effect on the degradation of
IκB. Thus, the inhibitory effect on NF-κB activitation
might be involved in the anti-inflammatory properties
of PLA.
In microglial activation, ROS production occurs prior
to the cytokine production and NO is another neurotoxic
factor [33, 36]. A recent study showed that alkaloids
from P. longum decreased ROS production, stabilized
mitochondrial membrane potential and inhibited the
opening of the mitochondrial permeability transition
pore (mPTP) [16]. In this study, we further investi-
gated the effects of PLA on production of neurotoxic
factors ROS and NO induced by LPS intranigral injection.
Our results indicated that PLA could reduce the produc-
tion of ROS and NO induced by LPS, which might be a
significant mediator of the neuroprotective effect of PLA.
Taking our previous work together, PLA might be a
multi-component and multi-target approach in the
treatment of PD. Further studies are needed to better
understand the mechanism involved in PD treatment.
Conclusion
In this study, the treatment of PLA, an active extract
of the traditional Chinese medicine P. longum, was able
to attenuate the depletion of DA and DOPAC in the
striatum, facilitate the survival of damaged neurons by
inhibiting microglial activation and suppressing the release
of neurotoxic factors such as TNF-α, IL-1β, IL-6, ROS and
NO, and improve the LPS-induced behavioral dysfunc-
tions. In summary, this study suggests that PLA may
Fig. 11 Effects of PLA treatment on the concentrations of ROS and NO in the SN. Rats were randomly grouped and then treated with
PLA (25, 50 and 75 mg/kg) or vehicle for 6 weeks after LPS injection. On day 42, rats were decapitated and the SN was used to detect
the concentration of ROS a by commercial ELISA kit and the concentration of NO b by NO assay kit. n = 6. **P < 0.01, ***P < 0.001 vs.
sham group, #P < 0.05, ##P < 0.01 vs. LPS group
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have a protective effect on dopaminergic neurons against
inflammatory reaction induced damage.
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